As GLP-1 medications move from clinical breakthrough to mainstream reality, the focus is shifting from rapid weight loss to the challenge of long-term maintenance. This digest explores the critical "maintenance gap" that emerges when pharmaceutical intervention ends and independent lifestyle habits must begin. Using our consumer insights, we examine how brands can transition from supporting short-term outcomes to becoming lifelong partners in sustained success. Download your copy to understand how to bridge the gap between clinical treatment and lasting lifestyle support.
Inside this digest:
How this helps brands:
Brands can learn to segment the support journey by recognizing that current and former users have distinct needs requiring tailored messaging. By prioritizing habit formation over short-term outcomes, companies can address the gap where appetite suppression ends and independent choices begin.